Cablivi “Now Approved” Web Page

Feb 13, 2019Feb 10, 2019

Brand: Cablivi (caplacizumab-yhdp), Injection
Parent Company: Sanofi Genzyme
Drug Type: Prescription
Drug Category: Hematology
Campaign: now-approved
Targeting: HCPs
Patient Website: https://www.cablivi.com/
HCP Website:

: ‘Now Approved’ Message

: Mobile

The gallery of digital pharma marketing screenshots.

Cablivi “Now Approved” Web Page

Your Email

Name
This field is for validation purposes and should be left unchanged.

We’ll never share or sell your personal info. Ever.